May 18, 1995 - Sopharma EAD and other companies establish consortium Pharmindustria AD in Razgrad, northeastern Bulgaria, in which Sopharma AD has a 12.5% stake. The newly founded company specialises in market research.

June 25, 1996 – Sopharma EAD takes over Sofia-based Nivalinpharma EOOD, engaged in research and development of phytochemicals.

June 25, 1999 – The Bulgarian Privatisation Agency sells a 67% stake in Sopharma AD to Irish Nova Technology Company Ltd for USD 32 mln. Later the privatisation contract is cancelled as Nova Technology Company Ltd fails to pay the contracted amount.

July 25, 2002 – Sopharma AD acquires a 100% stake in pharmaceutical trade company Pharmachim Holding EAD, Sofia, and a 45.89% stake in Sofia-based NIHFI AD, engaged in research and development of pharmaceuticals.

Aug 15, 2002 – The company acquires a 63.68% stake in trade company Pharmalogistika AD, Sofia.

Apr 22, 2004 – Sopharma AD acquires a 49% stake in Balgarska Roza-Sevtopolis AD, a pharmaceutical and cosmetics producer, based in Kazanlak, Bulgaria. In 2007 the company raises its stake in Balgarska Roza-Sevtopolis AD to 49.058%.

Oct 25, 2004 – The company decreases its stake in Pharmalogistica AD to 43.50% from 63.68%.

Nov 29, 2007 – The company increases its stake in Momina Krepost AD to 44.77%.

Feb 7, 2008 – Sopharma AD acquires 1.55% in Medica AD, a manufacturer of medical dressing materials, based in Sandanski, southwestern Bulgaria, and raises its stake to 90%. The company also increases its stake in Doverie Obedinen Holding to 23.44%.

Feb 21, 2008 – The company raises its stake in Momina Krepost to 48.27%.

November 2010 - Sopharma AD sets up the wholly owned subsidiary Sopharma Warsaw Sp. z o.o. in Warsaw, the capital of Poland. The newly established company sells Sopharma AD's products in Poland.

Nov 28, 2011 - The company lists on the Warsaw Stock Exchange.

Jan 31, 2012 - Sopharma's subsidiary Briz OOD buys 18% of OOO Vivaton Plus, Belarus. By the end of 2012 the total share - direct and indirect - of Sopharma in the company increases to 50%.

June 14, 2012 - Sopharma buys 6,149 shares in Maritsateks AD and increases its share in the capital of the company to 6.20%.

July 17, 2012 - Sopharma increases its share in Doverie United Holding AD to 18.7% from 14.97%.

Jan 23, 2013 - Financial Consultancy Company EOOD sells 4,053,002 shares in Sopharma AD and reduces its share in the company to 9.62%. Donev Investment Holding acquires 2,982,666 shares in Sopharma and increases its share to 26.79%.

Products and services

Sopharma AD's product portfolio includes more than 210 generic and branded drugs for human medicine, as well as pharmaceutical active substances in compliance with the international Good Manufacturing Practice (GMP) quality standards. The company's prescription and Over-The-Counter (OTC) drugs for almost all pharmacotherapeutic groups include: